My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 303

    1.

    Alpha-adrenergic receptor blockade with prazosin. Consideration of hypertension, heart failure, and potential new applications.

    Colucci WS.

    Ann Intern Med. 1982 Jul;97(1):67-77. Review.PMID: 6124197 [PubMed - indexed for MEDLINE]Related articles

    2.

    Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.

    Stanaszek WF, Kellerman D, Brogden RN, Romankiewicz JA.

    Drugs. 1983 Apr;25(4):339-84. Review.PMID: 6303744 [PubMed - indexed for MEDLINE]Related articles

    3.

    Role of the renin-angiotensin system in the development of hemodynamic and clinical tolerance to long-term prazosin therapy in patients with severe chronic heart failure.

    Packer M, Medina N, Yushak M.

    J Am Coll Cardiol. 1986 Mar;7(3):671-80.PMID: 2869077 [PubMed - indexed for MEDLINE]Related articles

    4.

    Adjunctive sympathoplegic therapy to ACE inhibition in Blacks with congestive heart failure: a comparison of alpha-1 with beta-1 blockade on exercise tolerance and cardiac sympathovagal reflex activity.

    Ajayi AA, Sofowora GG, Adigun AQ, Asiyanbola B.

    Ethn Dis. 2003 Winter;13(1):71-9.PMID: 12723015 [PubMed - indexed for MEDLINE]Related articles

    5.

    The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).

    Kluger J, Cody RJ, Laragh JH.

    Am J Cardiol. 1982 May;49(7):1667-74.PMID: 7044087 [PubMed - indexed for MEDLINE]Related articles

    6.

    Terazosin: a new long-acting alpha 1-adrenergic antagonist for hypertension.

    Frishman WH, Eisen G, Lapsker J.

    Med Clin North Am. 1988 Mar;72(2):441-8. Review.PMID: 2894488 [PubMed - indexed for MEDLINE]Related articles

    7.

    The pharmacokinetic, pharmacodynamic and haemodynamic effects of acute and chronic alpha-adrenoceptor blockade in chronic heart failure.

    Taylor SH, Silke B.

    Ann Acad Med Singapore. 1981 Oct;10(4 Suppl):45-51.PMID: 6124209 [PubMed - indexed for MEDLINE]Related articles

    8.

    Clinical, hemodynamic, and neuroendocrine effects of chronic prazosin therapy for congestive heart failure.

    Colucci WS, Williams GH, Braunwald E.

    Am Heart J. 1981 Sep;102(3 Pt 2):615-21. Review.PMID: 6115578 [PubMed - indexed for MEDLINE]Related articles

    9.

    Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure.

    Stein L, Henry DP, Weinberger MH.

    Am J Med. 1981 Apr;70(4):825-32.PMID: 7011023 [PubMed - indexed for MEDLINE]Related articles

    10.

    Hemodynamic and neuroendocrine responses to acute and chronic alpha-adrenergic blockade with prazosin and phenoxybenzamine.

    Mulvihill-Wilson J, Gaffney FA, Pettinger WA, Blomqvist CG, Anderson S, Graham RM.

    Circulation. 1983 Feb;67(2):383-93.PMID: 6129077 [PubMed - indexed for MEDLINE]Related articles

    11.

    Selective alpha 1-adrenergic antagonists: therapeutically relevant antihypertensive agents.

    Graham RM.

    Am J Cardiol. 1984 Jan 27;53(3):16A-20A. Review.PMID: 6141721 [PubMed - indexed for MEDLINE]Related articles

    12.

    Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.

    Titmarsh S, Monk JP.

    Drugs. 1987 May;33(5):461-77. Review.PMID: 2885169 [PubMed - indexed for MEDLINE]Related articles

    13.

    Chronic effects of direct vasodilation (pinacidil), alpha-adrenergic blockade (prazosin) and angiotensin-converting enzyme inhibition (captopril) in systemic hypertension.

    Izzo JL Jr, Licht MR, Smith RJ, Larrabee PS, Radke KJ, Kallay MC.

    Am J Cardiol. 1987 Aug 1;60(4):303-8.PMID: 2887102 [PubMed - indexed for MEDLINE]Related articles

    14.

    Increased plasma norepinephrine levels during prazosin therapy for severe congestive heart failure.

    Colucci WS, Williams GH, Braunwald E.

    Ann Intern Med. 1980 Sep;93(3):452-3.PMID: 7436166 [PubMed - indexed for MEDLINE]Related articles

    15.

    Management of refractory congestive heart failure with prazosin.

    Awan NA, Evenson MK, Needham KE, Mason DT.

    Am Heart J. 1981 Sep;102(3 Pt 2):626-34. Review.PMID: 6267922 [PubMed - indexed for MEDLINE]Related articles

    16.

    Attenuation of prazosin effect on cardiac output in chronic heart failure.

    Arnold SB, Williams RL, Ports TA, Baughman RA, Benet LZ, Parmley WW, Chatterjee K.

    Ann Intern Med. 1979 Sep;91(3):345-9.PMID: 475164 [PubMed - indexed for MEDLINE]Related articles

    17.

    Clinical and hemodynamic improvement of congestive heart failure by long-term vasodilator therapy with postjunctional alpha 1-adrenoceptor blockade.

    Bertel O, Bühler FR, Burkart F.

    J Cardiovasc Pharmacol. 1982;4 Suppl 1:S181-6.PMID: 6175837 [PubMed - indexed for MEDLINE]Related articles

    18.

    Pharmacologic basis for the use of doxazosin in the treatment of essential hypertension.

    Davey MJ.

    Am J Med. 1989 Aug 16;87(2A):36S-44S. Review.PMID: 2569823 [PubMed - indexed for MEDLINE]Related articles

    19.

    Hemodynamic and endocrinological effects of a new selective alpha 1-blocking agent, terazosin, in patients with essential hypertension. Results of long-term treatment.

    Tomoda F, Takata M, Yoshida K, Yasumoto K, Mikawa M, Sasayama S.

    Am J Hypertens. 1989 Nov;2(11 Pt 1):834-9.PMID: 2574044 [PubMed - indexed for MEDLINE]Related articles

    20.

    Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.

    Awan NA, Needham KE, Evenson MK, Amsterdam EE, Mason DT.

    Am J Med. 1981 Jul;71(1):153-60.PMID: 7246573 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity